PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Sep-2020 Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study Ena Respiratory
25-Sep-2020 FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years U.S. Food and Drug Administration
25-Sep-2020 RemeGen Announces US FDA Has Granted Breakthrough Therapy Designation for Disitamab Vedotin (RC48) in Urothelial Cancer RemeGen Co., Ltd.
25-Sep-2020 GRAM Partners with Johnson & Johnson on Manufacturing in Fight Against COVID-19 Grand River Aseptic Manufacturing
25-Sep-2020 Dutch Amarna Therapeutics Enters Research Collaboration with Spanish FPS, Examining the Efficacy of its SV40-Based SVec™ Gene Delivery Vector Platform Technology in Diabetes Mellitus Type 1 and Multiple Sclerosis B3C newswire
25-Sep-2020 AI for Biopharmaceutical Production – Sartorius a New Shareholder in DFKI, the German Research Center for Artificial Intelligence B3C newswire
25-Sep-2020 THE LANCET publishes promising data of APEIRON's APN01 (rhsACE2) to treat COVID-19 in named patient use APEIRON Biologics AG
25-Sep-2020 RHÖN-KLINIKUM Aktiengesellschaft sells shares in Medgate Deutschland GmbH RHÖN-KLINIKUM Aktiengesellschaft
24-Sep-2020 FDA In Brief: FDA Advises Restaurants to Not Sell or Serve Recalled Wood Ear Mushrooms, Investigation Continues U.S. Food and Drug Administration
24-Sep-2020 Abivax presents first-half 2020 financial results and operations update (news with additional features) ABIVAX
24-Sep-2020 Servier and MBC BioLabs Announce Winner of the 2020 Servier Golden Ticket Servier Pharmaceuticals
24-Sep-2020 Theralink® Technologies Announces Corporate Name Change Theralink Technologies
24-Sep-2020 Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis Sygnature Discovery
24-Sep-2020 LifeArc and UK government’s Future Fund provide £3.0m in funding to Avvinity Therapeutics LifeArc
24-Sep-2020 TEVA SURVEY DRIVES CALL-TO-ACTION AND COMMITMENT TO IMPROVING THE QUALITY OF LIFE FOR ‘FORGOTTEN’ MIGRAINE POPULATION1,2 TEVA
24-Sep-2020 Hoth Therapeutics Announces its HT-003 Shows Positive Initial Data Inhibiting Toll-like Receptor 2 (TLR2) Hoth Therapeutics, Inc.
24-Sep-2020 Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis Sygnature Discovery
24-Sep-2020 New Liquid Chromatography-Mass Spectrometry Workstream offers Comprehensive Solution for Toxicology Thermo Fisher Scientific
24-Sep-2020 Two out of three leading COVID-19 vaccine initiatives utilising Generis's Life Science Platform, CARA Generis
24-Sep-2020 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG